Navigation Links
ChemoCentryx Announces Pricing of Initial Public Offering
Date:2/8/2012

MOUNTAIN VIEW, Calif., Feb. 8, 2012 /PRNewswire/ -- ChemoCentryx, Inc. (NASDAQ: CCXI) announced today the pricing of its initial public offering of 4,500,000 shares of its common stock at $10.00 per share, before underwriting discounts and commissions. All of the common stock is being offered by ChemoCentryx. In addition, the underwriters have a 30-day option to purchase up to an additional 675,000 shares of common stock from ChemoCentryx to cover over-allotments, if any.

Shares of ChemoCentryx's common stock will trade on the NASDAQ Global Select Market under the symbol "CCXI" beginning on February 8, 2012. The offering is expected to close on February 13, 2012, subject to customary closing conditions.

J.P. Morgan Securities LLC and Citigroup are acting as joint book-running managers of the offering, and Cowen and Company, LLC is acting as co-manager of the offering.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on February 8, 2012. This offering is being made only by means of a prospectus, copies of which may be obtained from J. P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by phone at 866-803-9204, or from Citigroup, Attn: Prospectus Delivery Department, Brooklyn Army Terminal, 140 58th Street, Brooklyn, New York 11220 or by phone at 718-765-6732.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About ChemoCentryx 

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the c
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis
2. ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis
3. ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes
4. ChemoCentryx Initiates Phase I Clinical Trial of CCX832, the First Small Molecule Inhibitor of ChemR23
5. ChemoCentryx to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)
7. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
8. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
9. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
10. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
11. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015 Mallinckrodt plc ... company, today announced that it has completed its ... of approximately $2.3 billion. The Ikaria acquisition extends ... its reach into neonatal critical care with INOMAX ... option for a highly vulnerable patient population. It ...
(Date:4/16/2015)... FLINT, Mich. , April 16, 2015  Diplomat ... of Shannon Beltrand to their senior leadership ... Beltrand will be responsible for securing and properly monitoring ... is secure both internally and externally. Additionally, she will ... planning. "We are very excited to ...
(Date:4/16/2015)... -- An IAVI -led team of scientists has ... major HIV subtypes A, B and C, with scalable ... vaccine candidates designed to elicit broadly neutralizing antibodies. The ... HIV for such antibodies. The new ... says Rich Wyatt , senior director, viral immunology, ...
Breaking Medicine Technology:Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5Diplomat Names Shannon M. Beltrand as New CISO 2New Method Holds Promise for HIV Vaccine Development 2
... Inc. (NYSE: CRY ), a leading ... surgery, announced today that it has completed its ... and markets the HeRO (Hemodialysis Reliable Outflow) Graft, ... (ESRD) hemodialysis patients with limited access options and ...
... UBM Conferences , a division of UBM Plc (LSE: ... and Leachables Webinar to be hosted on May 17th, ... attend webinar will evaluate the considerations to be made ... in addition to highlighting how monomers and additives, such ...
Cached Medicine Technology:CryoLife Completes Acquisition of Hemosphere 2CryoLife Completes Acquisition of Hemosphere 3CryoLife Completes Acquisition of Hemosphere 4Global Webinar Focuses on Considerations for Extractables and Leachables 2
(Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... a turbulent world, people may find themselves in dangerous situations ... first move, but some situations can be avoided if there ...
(Date:4/17/2015)... Bradley, Illinois (PRWEB) April 18, 2015 ... community, will begin its Supportive Living Week Celebration on ... focus on having a healthy mind, body and soul. ... Marshall in McLeansboro, Illinois, serves older adults of all ... to maintain their independence. , Supportive Living Week is ...
(Date:4/17/2015)... ERGO-Pedic Products, LLC, which produces therapeutic memory foam ... help a broader range of people plagued by pain. ... most common visitors to doctors. , “The ERGO-Pedic Comfort ... relieve sitting pain. Then, only a couple months after ... later, we began getting questions from those customers, asking ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at Connerton ... all selected as Top Workplaces in Tampa Bay. ... ranked number one for large businesses according to the ... partnership with an independent research firm. Florida Hospital Wesley ... in October of 2012 with a vision of excellence ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4
... change how millions worldwide ... disease, DENVER, Oct. 21 Corgenix Medical Corporation,(OTC ... in Circulation confirm that elevated urinary levels of the,biomarker ... attack, stroke and cardiac death., The AspirinWorks(R) Test ...
... VANCOUVER, Oct. 21 /PRNewswire-FirstCall/ - CRH Medical ... few months it has trained,over 100 Gastroenterologists ... sell,the Company,s patented proprietary hemorrhoid banding technology ... approach complements,its core strategy of operating Centers ...
... Weight Watchers,International, Inc. (NYSE: WTW ) will ... NYSE close on Tuesday, November 4, 2008., The ... 4th at,5:00 p.m. ET. During the conference call, David ... Financial Officer, will,discuss third quarter results and answer questions ...
... score the title of Body By Milk MVP, ... fit has,become second nature to the superstar athletes at ... campaign announced today that the,Tigers Varsity football team has ... Players). The team was nominated to be part of ...
... 21 VIASPACE Inc. (OTC,Bulletin Board: VSPC) ... II contract for its proposal entitled "Miniature ... Aerial Vehicles (VTUAVs)" by the Navy,s,Small Business ... year contract will result in a field ...
... BOCA RATON, Fla., Oct. 21 The weight management ... the latest,addition to its Smart product line, the Smart ... a bagel on its head., The Smart Bagel ... the consumer full and satisfied for hours. Unique among,bagels, ...
Cached Medicine News:Health News:New CHARISMA Outcome Study Results Validate Aspirin Effect 2Health News:New CHARISMA Outcome Study Results Validate Aspirin Effect 3Health News:New CHARISMA Outcome Study Results Validate Aspirin Effect 4Health News:CRH Medical Corporation reaches milestone in partnership program 2Health News:CRH Medical Corporation reaches milestone in partnership program 3Health News:Weight Watchers Announces Third Quarter 2008 Earnings Conference Call 2Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 2Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 3Health News:VIASPACE Subsidiary Wins $786,000 U.S. Navy Contract 2Health News:Smart for Life(TM) Announces the New and Improved Bagel 2
... multi-purpose topical gel contains 10% Povidone Iodine ... action. As a pre-operative prep, Povidone Iodine ... prepping solutions under the patient, thus reducing ... is also approved as a one step ...
... Iodine Prep Solution is appropriate for ... wet soak or spray); disinfecting of ... treatment of lacerations and abrasions. It ... agent in hospital and office procedures, ...
... Aplicare's Prep-Swab Ampule is ... a plastic tube that is ... has an absorbent applicator at ... tube is squeezed to break ...
... can be a valuable tool in standardizing ... items necessary for a procedure are supplied ... continuum of care are easier to be ... sequence of use, allowing the clinician to ...
Medicine Products: